 | • レポートコード：GIR-2104Z08735 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、男性性腺機能低下症のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。男性性腺機能低下症の種類別市場規模（テストステロン補充療法、ゴナドトロピン放出ホルモン療法）、用途別市場規模（カルマン症候群、クラインフェルター症候群、下垂体障害、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・男性性腺機能低下症の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Astrazeneca Plc.、Merck & Co. Inc.、Laboratories Genevrier、Allergan Plc.、Endo International Plc.、Ferring、AbbVie Inc.、Eli Lilly and Company Ltd.、Finox Biotech、Teva Pharmaceutical Industries Ltd.、Bayer AG、IBSA Institut Biochimque ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：テストステロン補充療法、ゴナドトロピン放出ホルモン療法 ・用途別分析2016年-2026年：カルマン症候群、クラインフェルター症候群、下垂体障害、その他 ・男性性腺機能低下症の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・男性性腺機能低下症のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・男性性腺機能低下症のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・男性性腺機能低下症の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・男性性腺機能低下症の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Male Hypogonadism market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Male Hypogonadism size is estimated to be USD 3448.5 million in 2025 from USD 3139.6 million in 2019, with a change XX% between 2019 and 2020. The global Male Hypogonadism market size is expected to grow at a CAGR of 2.4% for the next five years.
Market segmentation
Male Hypogonadism market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Testosterone Replacement Therapy
Gonadotropin-Releasing Hormones Therapy
Market segment by Application, can be divided into
Kallmann Syndrome
Klinefelters Syndrome
Pituitary Disorders
Others
Market segment by players, this report covers
Astrazeneca Plc.
Merck & Co. Inc.
Laboratories Genevrier
Allergan Plc.
Endo International Plc.
Ferring
AbbVie Inc.
Eli Lilly and Company Ltd.
Finox Biotech
Teva Pharmaceutical Industries Ltd.
Bayer AG
IBSA Institut Biochimque
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Male Hypogonadism
1.2 Classification of Male Hypogonadism by Type
1.2.1 Overview: Global Male Hypogonadism Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Male Hypogonadism Revenue Market Share by Type in 2020
1.2.3 Testosterone Replacement Therapy
1.2.4 Gonadotropin-Releasing Hormones Therapy
1.3 Global Male Hypogonadism Market by Application
1.3.1 Overview: Global Male Hypogonadism Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Kallmann Syndrome
1.3.3 Klinefelters Syndrome
1.3.4 Pituitary Disorders
1.3.5 Others
1.4 Global Male Hypogonadism Market Size & Forecast
1.5 Global Male Hypogonadism Market Size and Forecast by Region
1.5.1 Global Male Hypogonadism Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Male Hypogonadism Market Size by Region, (2016-2021)
1.5.3 North America Male Hypogonadism Market Size and Prospect (2016-2026)
1.5.4 Europe Male Hypogonadism Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Male Hypogonadism Market Size and Prospect (2016-2026)
1.5.6 South America Male Hypogonadism Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Male Hypogonadism Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Male Hypogonadism Market Drivers
1.6.2 Male Hypogonadism Market Restraints
1.6.3 Male Hypogonadism Trends Analysis
2 Company Profiles
2.1 Astrazeneca Plc.
2.1.1 Astrazeneca Plc. Details
2.1.2 Astrazeneca Plc. Major Business
2.1.3 Astrazeneca Plc. Male Hypogonadism Product and Solutions
2.1.4 Astrazeneca Plc. Male Hypogonadism Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Astrazeneca Plc. Recent Developments and Future Plans
2.2 Merck & Co. Inc.
2.2.1 Merck & Co. Inc. Details
2.2.2 Merck & Co. Inc. Major Business
2.2.3 Merck & Co. Inc. Male Hypogonadism Product and Solutions
2.2.4 Merck & Co. Inc. Male Hypogonadism Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Merck & Co. Inc. Recent Developments and Future Plans
2.3 Laboratories Genevrier
2.3.1 Laboratories Genevrier Details
2.3.2 Laboratories Genevrier Major Business
2.3.3 Laboratories Genevrier Male Hypogonadism Product and Solutions
2.3.4 Laboratories Genevrier Male Hypogonadism Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Laboratories Genevrier Recent Developments and Future Plans
2.4 Allergan Plc.
2.4.1 Allergan Plc. Details
2.4.2 Allergan Plc. Major Business
2.4.3 Allergan Plc. Male Hypogonadism Product and Solutions
2.4.4 Allergan Plc. Male Hypogonadism Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Allergan Plc. Recent Developments and Future Plans
2.5 Endo International Plc.
2.5.1 Endo International Plc. Details
2.5.2 Endo International Plc. Major Business
2.5.3 Endo International Plc. Male Hypogonadism Product and Solutions
2.5.4 Endo International Plc. Male Hypogonadism Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Endo International Plc. Recent Developments and Future Plans
2.6 Ferring
2.6.1 Ferring Details
2.6.2 Ferring Major Business
2.6.3 Ferring Male Hypogonadism Product and Solutions
2.6.4 Ferring Male Hypogonadism Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Ferring Recent Developments and Future Plans
2.7 AbbVie Inc.
2.7.1 AbbVie Inc. Details
2.7.2 AbbVie Inc. Major Business
2.7.3 AbbVie Inc. Male Hypogonadism Product and Solutions
2.7.4 AbbVie Inc. Male Hypogonadism Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 AbbVie Inc. Recent Developments and Future Plans
2.8 Eli Lilly and Company Ltd.
2.8.1 Eli Lilly and Company Ltd. Details
2.8.2 Eli Lilly and Company Ltd. Major Business
2.8.3 Eli Lilly and Company Ltd. Male Hypogonadism Product and Solutions
2.8.4 Eli Lilly and Company Ltd. Male Hypogonadism Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Eli Lilly and Company Ltd. Recent Developments and Future Plans
2.9 Finox Biotech
2.9.1 Finox Biotech Details
2.9.2 Finox Biotech Major Business
2.9.3 Finox Biotech Male Hypogonadism Product and Solutions
2.9.4 Finox Biotech Male Hypogonadism Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Finox Biotech Recent Developments and Future Plans
2.10 Teva Pharmaceutical Industries Ltd.
2.10.1 Teva Pharmaceutical Industries Ltd. Details
2.10.2 Teva Pharmaceutical Industries Ltd. Major Business
2.10.3 Teva Pharmaceutical Industries Ltd. Male Hypogonadism Product and Solutions
2.10.4 Teva Pharmaceutical Industries Ltd. Male Hypogonadism Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Teva Pharmaceutical Industries Ltd. Recent Developments and Future Plans
2.11 Bayer AG
2.11.1 Bayer AG Details
2.11.2 Bayer AG Major Business
2.11.3 Bayer AG Male Hypogonadism Product and Solutions
2.11.4 Bayer AG Male Hypogonadism Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Bayer AG Recent Developments and Future Plans
2.12 IBSA Institut Biochimque
2.12.1 IBSA Institut Biochimque Details
2.12.2 IBSA Institut Biochimque Major Business
2.12.3 IBSA Institut Biochimque Male Hypogonadism Product and Solutions
2.12.4 IBSA Institut Biochimque Male Hypogonadism Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 IBSA Institut Biochimque Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Male Hypogonadism Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Male Hypogonadism Players Market Share
3.2.2 Top 10 Male Hypogonadism Players Market Share
3.2.3 Market Competition Trend
3.3 Male Hypogonadism Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Male Hypogonadism Revenue and Market Share by Type (2016-2021)
4.2 Global Male Hypogonadism Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Male Hypogonadism Revenue Market Share by Application (2016-2021)
5.2 Male Hypogonadism Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Male Hypogonadism Revenue by Type (2016-2026)
6.2 North America Male Hypogonadism Revenue by Application (2016-2026)
6.3 North America Male Hypogonadism Market Size by Country
6.3.1 North America Male Hypogonadism Revenue by Country (2016-2026)
6.3.2 United States Male Hypogonadism Market Size and Forecast (2016-2026)
6.3.3 Canada Male Hypogonadism Market Size and Forecast (2016-2026)
6.3.4 Mexico Male Hypogonadism Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Male Hypogonadism Revenue by Type (2016-2026)
7.2 Europe Male Hypogonadism Revenue by Application (2016-2026)
7.3 Europe Male Hypogonadism Market Size by Country
7.3.1 Europe Male Hypogonadism Revenue by Country (2016-2026)
7.3.2 Germany Male Hypogonadism Market Size and Forecast (2016-2026)
7.3.3 France Male Hypogonadism Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Male Hypogonadism Market Size and Forecast (2016-2026)
7.3.5 Russia Male Hypogonadism Market Size and Forecast (2016-2026)
7.3.6 Italy Male Hypogonadism Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Male Hypogonadism Revenue by Type (2016-2026)
8.2 Asia-Pacific Male Hypogonadism Revenue by Application (2016-2026)
8.3 Asia-Pacific Male Hypogonadism Market Size by Region
8.3.1 Asia-Pacific Male Hypogonadism Revenue by Region (2016-2026)
8.3.2 China Male Hypogonadism Market Size and Forecast (2016-2026)
8.3.3 Japan Male Hypogonadism Market Size and Forecast (2016-2026)
8.3.4 South Korea Male Hypogonadism Market Size and Forecast (2016-2026)
8.3.5 India Male Hypogonadism Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Male Hypogonadism Market Size and Forecast (2016-2026)
8.3.7 Australia Male Hypogonadism Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Male Hypogonadism Revenue by Type (2016-2026)
9.2 South America Male Hypogonadism Revenue by Application (2016-2026)
9.3 South America Male Hypogonadism Market Size by Country
9.3.1 South America Male Hypogonadism Revenue by Country (2016-2026)
9.3.2 Brazil Male Hypogonadism Market Size and Forecast (2016-2026)
9.3.3 Argentina Male Hypogonadism Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Male Hypogonadism Revenue by Type (2016-2026)
10.2 Middle East & Africa Male Hypogonadism Revenue by Application (2016-2026)
10.3 Middle East & Africa Male Hypogonadism Market Size by Country
10.3.1 Middle East & Africa Male Hypogonadism Revenue by Country (2016-2026)
10.3.2 Turkey Male Hypogonadism Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Male Hypogonadism Market Size and Forecast (2016-2026)
10.3.4 UAE Male Hypogonadism Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Male Hypogonadism Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Male Hypogonadism Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Male Hypogonadism Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Male Hypogonadism Revenue (USD Million) by Region (2016-2021)
Table 5. Global Male Hypogonadism Revenue Market Share by Region (2021-2026)
Table 6. Astrazeneca Plc. Corporate Information, Head Office, and Major Competitors
Table 7. Astrazeneca Plc. Major Business
Table 8. Astrazeneca Plc. Male Hypogonadism Product and Solutions
Table 9. Astrazeneca Plc. Male Hypogonadism Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Merck & Co. Inc. Corporate Information, Head Office, and Major Competitors
Table 11. Merck & Co. Inc. Major Business
Table 12. Merck & Co. Inc. Male Hypogonadism Product and Solutions
Table 13. Merck & Co. Inc. Male Hypogonadism Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Laboratories Genevrier Corporate Information, Head Office, and Major Competitors
Table 15. Laboratories Genevrier Major Business
Table 16. Laboratories Genevrier Male Hypogonadism Product and Solutions
Table 17. Laboratories Genevrier Male Hypogonadism Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Allergan Plc. Corporate Information, Head Office, and Major Competitors
Table 19. Allergan Plc. Major Business
Table 20. Allergan Plc. Male Hypogonadism Product and Solutions
Table 21. Allergan Plc. Male Hypogonadism Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Endo International Plc. Corporate Information, Head Office, and Major Competitors
Table 23. Endo International Plc. Major Business
Table 24. Endo International Plc. Male Hypogonadism Product and Solutions
Table 25. Endo International Plc. Male Hypogonadism Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Ferring Corporate Information, Head Office, and Major Competitors
Table 27. Ferring Major Business
Table 28. Ferring Male Hypogonadism Product and Solutions
Table 29. Ferring Male Hypogonadism Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. AbbVie Inc. Corporate Information, Head Office, and Major Competitors
Table 31. AbbVie Inc. Major Business
Table 32. AbbVie Inc. Male Hypogonadism Product and Solutions
Table 33. AbbVie Inc. Male Hypogonadism Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Eli Lilly and Company Ltd. Corporate Information, Head Office, and Major Competitors
Table 35. Eli Lilly and Company Ltd. Major Business
Table 36. Eli Lilly and Company Ltd. Male Hypogonadism Product and Solutions
Table 37. Eli Lilly and Company Ltd. Male Hypogonadism Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Finox Biotech Corporate Information, Head Office, and Major Competitors
Table 39. Finox Biotech Major Business
Table 40. Finox Biotech Male Hypogonadism Product and Solutions
Table 41. Finox Biotech Male Hypogonadism Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Teva Pharmaceutical Industries Ltd. Corporate Information, Head Office, and Major Competitors
Table 43. Teva Pharmaceutical Industries Ltd. Major Business
Table 44. Teva Pharmaceutical Industries Ltd. Male Hypogonadism Product and Solutions
Table 45. Teva Pharmaceutical Industries Ltd. Male Hypogonadism Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Bayer AG Corporate Information, Head Office, and Major Competitors
Table 47. Bayer AG Major Business
Table 48. Bayer AG Male Hypogonadism Product and Solutions
Table 49. Bayer AG Male Hypogonadism Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. IBSA Institut Biochimque Corporate Information, Head Office, and Major Competitors
Table 51. IBSA Institut Biochimque Major Business
Table 52. IBSA Institut Biochimque Male Hypogonadism Product and Solutions
Table 53. IBSA Institut Biochimque Male Hypogonadism Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Global Male Hypogonadism Revenue (USD Million) by Players (2019-2021)
Table 55. Global Male Hypogonadism Revenue Share by Players (2019-2021)
Table 56. Breakdown of Male Hypogonadism by Company Type (Tier 1, Tier 2 and Tier 3)
Table 57. Male Hypogonadism Players Head Office, Products and Services Provided
Table 58. Male Hypogonadism Mergers & Acquisitions in the Past Five Years
Table 59. Male Hypogonadism New Entrants and Expansion Plans
Table 60. Global Male Hypogonadism Revenue (USD Million) by Type (2016-2021)
Table 61. Global Male Hypogonadism Revenue Share by Type (2016-2021)
Table 62. Global Male Hypogonadism Revenue Forecast by Type (2021-2026)
Table 63. Global Male Hypogonadism Revenue by Application (2016-2021)
Table 64. Global Male Hypogonadism Revenue Forecast by Application (2021-2026)
Table 65. North America Male Hypogonadism Revenue by Type (2016-2021) & (USD Million)
Table 66. North America Male Hypogonadism Revenue by Type (2021-2026) & (USD Million)
Table 67. North America Male Hypogonadism Revenue by Application (2016-2021) & (USD Million)
Table 68. North America Male Hypogonadism Revenue by Application (2021-2026) & (USD Million)
Table 69. North America Male Hypogonadism Revenue by Country (2016-2021) & (USD Million)
Table 70. North America Male Hypogonadism Revenue by Country (2021-2026) & (USD Million)
Table 71. Europe Male Hypogonadism Revenue by Type (2016-2021) & (USD Million)
Table 72. Europe Male Hypogonadism Revenue by Type (2021-2026) & (USD Million)
Table 73. Europe Male Hypogonadism Revenue by Application (2016-2021) & (USD Million)
Table 74. Europe Male Hypogonadism Revenue by Application (2021-2026) & (USD Million)
Table 75. Europe Male Hypogonadism Revenue by Country (2016-2021) & (USD Million)
Table 76. Europe Male Hypogonadism Revenue by Country (2021-2026) & (USD Million)
Table 77. Asia-Pacific Male Hypogonadism Revenue by Type (2016-2021) & (USD Million)
Table 78. Asia-Pacific Male Hypogonadism Revenue by Type (2021-2026) & (USD Million)
Table 79. Asia-Pacific Male Hypogonadism Revenue by Application (2016-2021) & (USD Million)
Table 80. Asia-Pacific Male Hypogonadism Revenue by Application (2021-2026) & (USD Million)
Table 81. Asia-Pacific Male Hypogonadism Revenue by Region (2016-2021) & (USD Million)
Table 82. Asia-Pacific Male Hypogonadism Revenue by Region (2021-2026) & (USD Million)
Table 83. South America Male Hypogonadism Revenue by Type (2016-2021) & (USD Million)
Table 84. South America Male Hypogonadism Revenue by Type (2021-2026) & (USD Million)
Table 85. South America Male Hypogonadism Revenue by Application (2016-2021) & (USD Million)
Table 86. South America Male Hypogonadism Revenue by Application (2021-2026) & (USD Million)
Table 87. South America Male Hypogonadism Revenue by Country (2016-2021) & (USD Million)
Table 88. South America Male Hypogonadism Revenue by Country (2021-2026) & (USD Million)
Table 89. Middle East & Africa Male Hypogonadism Revenue by Type (2016-2021) & (USD Million)
Table 90. Middle East & Africa Male Hypogonadism Revenue by Type (2021-2026) & (USD Million)
Table 91. Middle East & Africa Male Hypogonadism Revenue by Application (2016-2021) & (USD Million)
Table 92. Middle East & Africa Male Hypogonadism Revenue by Application (2021-2026) & (USD Million)
Table 93. Middle East & Africa Male Hypogonadism Revenue by Country (2016-2021) & (USD Million)
Table 94. Middle East & Africa Male Hypogonadism Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Male Hypogonadism Picture
Figure 2. Global Male Hypogonadism Revenue Market Share by Type in 2020
Figure 3. Testosterone Replacement Therapy
Figure 4. Gonadotropin-Releasing Hormones Therapy
Figure 5. Male Hypogonadism Revenue Market Share by Application in 2020
Figure 6. Kallmann Syndrome Picture
Figure 7. Klinefelters Syndrome Picture
Figure 8. Pituitary Disorders Picture
Figure 9. Others Picture
Figure 10. Global Male Hypogonadism Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Male Hypogonadism Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Male Hypogonadism Revenue Market Share by Region (2016-2026)
Figure 13. Global Male Hypogonadism Revenue Market Share by Region in 2020
Figure 14. North America Male Hypogonadism Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Male Hypogonadism Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Male Hypogonadism Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Male Hypogonadism Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Male Hypogonadism Market Drivers
Figure 19. Male Hypogonadism Market Restraints
Figure 20. Male Hypogonadism Market Trends
Figure 21. Astrazeneca Plc. Recent Developments and Future Plans
Figure 22. Merck & Co. Inc. Recent Developments and Future Plans
Figure 23. Laboratories Genevrier Recent Developments and Future Plans
Figure 24. Allergan Plc. Recent Developments and Future Plans
Figure 25. Endo International Plc. Recent Developments and Future Plans
Figure 26. Ferring Recent Developments and Future Plans
Figure 27. AbbVie Inc. Recent Developments and Future Plans
Figure 28. Eli Lilly and Company Ltd. Recent Developments and Future Plans
Figure 29. Finox Biotech Recent Developments and Future Plans
Figure 30. Teva Pharmaceutical Industries Ltd. Recent Developments and Future Plans
Figure 31. Bayer AG Recent Developments and Future Plans
Figure 32. IBSA Institut Biochimque Recent Developments and Future Plans
Figure 34. Global Male Hypogonadism Revenue Share by Players in 2020
Figure 35. Male Hypogonadism Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 36. Global Top 3 Players Male Hypogonadism Revenue Market Share in 2020
Figure 37. Global Top 10 Players Male Hypogonadism Revenue Market Share in 2020
Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 39. Global Male Hypogonadism Revenue Share by Type in 2020
Figure 40. Global Male Hypogonadism Market Share Forecast by Type (2021-2026)
Figure 41. Global Male Hypogonadism Revenue Share by Application in 2020
Figure 42. Global Male Hypogonadism Market Share Forecast by Application (2021-2026)
Figure 43. North America Male Hypogonadism Sales Market Share by Type (2016-2026)
Figure 44. North America Male Hypogonadism Sales Market Share by Application (2016-2026)
Figure 45. North America Male Hypogonadism Revenue Market Share by Country (2016-2026)
Figure 46. United States Male Hypogonadism Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Canada Male Hypogonadism Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Mexico Male Hypogonadism Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Europe Male Hypogonadism Sales Market Share by Type (2016-2026)
Figure 50. Europe Male Hypogonadism Sales Market Share by Application (2016-2026)
Figure 51. Europe Male Hypogonadism Revenue Market Share by Country (2016-2026)
Figure 52. Germany Male Hypogonadism Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France Male Hypogonadism Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom Male Hypogonadism Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia Male Hypogonadism Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy Male Hypogonadism Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific Male Hypogonadism Sales Market Share by Type (2016-2026)
Figure 58. Asia-Pacific Male Hypogonadism Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific Male Hypogonadism Revenue Market Share by Region (2016-2026)
Figure 60. China Male Hypogonadism Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan Male Hypogonadism Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South Korea Male Hypogonadism Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India Male Hypogonadism Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia Male Hypogonadism Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia Male Hypogonadism Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America Male Hypogonadism Sales Market Share by Type (2016-2026)
Figure 67. South America Male Hypogonadism Sales Market Share by Application (2016-2026)
Figure 68. South America Male Hypogonadism Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Male Hypogonadism Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Male Hypogonadism Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East and Africa Male Hypogonadism Sales Market Share by Type (2016-2026)
Figure 72. Middle East and Africa Male Hypogonadism Sales Market Share by Application (2016-2026)
Figure 73. Middle East and Africa Male Hypogonadism Revenue Market Share by Country (2016-2026)
Figure 74. Turkey Male Hypogonadism Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia Male Hypogonadism Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. UAE Male Hypogonadism Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Methodology
Figure 78. Research Process and Data Source
世界の男性不妊症市場規模・現状・予測（2021年-2027年） Male infertility is defined as the inability of a male to impregnate his female partner after a year of unprotected intercourse. The major factors driving the male infertility market are the change in lifestyle, increasing age, environmental effects, etc., and these factors are majorly contributing …- 世界の男性不妊症市場規模・現状・予測（2021年-2027年） Male infertility is defined as the inability of a male to impregnate his female partner after a year of unprotected intercourse. The major factors driving the male infertility market are the change in lifestyle, increasing age, environmental effects, etc., and these factors are majorly contributing …
- 世界の男性不妊治療市場規模・現状・予測（2021年-2027年） According to Word Health Organization, ‘Infertility is the inability of a sexually active, non-contraception couple to achieve pregnancy in one year’. About 15% of couples do not achieve pregnancy within 1year and seeking for infertility medical treatment. Less than 5% of world population is unwilli…
- 世界の男性不妊治療市場 2021：企業別、地域別、種類・用途別 The Male Infertility Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regu…
- 世界の男性用美容市場規模・現状・予測（2021年-2027年） Male Aesthetics is the study and application of beauty treatment for the man. According to the report, one driver in market is rising demand for non-surgical procedures. Market Analysis and Insights: Global Male Aesthetics Market The global Male Aesthetics market size is projected to reach US$ XX mi…